跳至主要内容
临床试验/NCT07287059
NCT07287059招募中不适用

Effects of Wearable Robotic and Virtual Reality-Assisted Interventions on Hand Function in Stroke Rehabilitation

Medipol University1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2025年12月20日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
42
试验地点
1
主要终点
Hand Function - Chedoke Arm and Hand Activity Inventory (CAHAI)

研究概览

简要总结

Stroke is a common neurological disorder resulting from acute focal damage to the central nervous system due to vascular events such as cerebral infarction, intracerebral hemorrhage, or subarachnoid hemorrhage. It represents one of the leading causes of mortality and long-term disability in adults, with approximately 85 % of cases being ischemic and 15 % hemorrhagic. Among survivors, up to 70 % experience upper-limb functional loss and about 40 % remain chronically impaired, particularly in wrist and hand extension due to synergy patterns and spasticity. Rehabilitation targeting upper-limb motor recovery is therefore crucial for improving activities of daily living and social participation. Technology-assisted interventions such as wearable soft robotic gloves and virtual-reality-based motion-tracking devices have recently been introduced to enhance neuroplasticity, improve voluntary movement quality, and facilitate functional independence.

This multicenter, randomized controlled clinical trial will be conducted between November 2025 and June 2026. The study will include adults aged 30-60 years with a confirmed diagnosis of post-stroke hemiplegia (ICD-10: G81) who meet the predefined inclusion criteria-including Mini-Mental State Examination > 24, Modified Ashworth Scale < 3, wrist extension > 10°, Brunnstrom stage > 3, and Fugl-Meyer Upper-Limb score > 22-will be recruited after written informed consent. Exclusion criteria include significant neglect or visual deficits, communication disorders, peripheral nerve injury, botulinum toxin injection within the previous six months, major orthopedic surgery of the affected limb, or serious systemic comorbidities. Eligible participants will be randomly assigned to one of three groups for six weeks of therapy, three sessions per week: (1) Neurodevelopmental therapy (NDT) and wearable Soft Robotic Glove (SRG); (2) NDT and Leap Motion Controller (LMC) integrated with the Becure platform (HandROM and ErgoActive modules including LeapBall, Piano, PinchPeg, and Hold-and-Put tasks); or (3) NDT-only control group performing standard task-oriented hand exercises.

Assessments will be performed at baseline and after the 18th treatment session and will include demographic data, Box-and-Block Test, Chedoke Arm and Hand Activity Inventory, surface electromyography for muscle strength, and joint-angle measurements using LMC-based Becure HandROM. The primary outcomes of this study are upper-limb functional performance and hand dexterity, while the secondary outcomes include joint range of motion, grip-pattern kinematics, and muscle strength. The findings are expected to compare and determine the effectiveness of wearable soft robotic-assisted and virtual reality-assisted interventions in post-stroke upper-limb rehabilitation, thereby guiding the evidence-based integration of advanced technologies into routine neurorehabilitation practice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of stroke
  • Mini-Mental State Examination score > 24
  • Modified Ashworth Scale score < 3
  • Active wrist extension > 10°
  • Brunnstrom stage > 3
  • Fugl-Meyer Upper Extremity score > 22

排除标准

  • Presence of significant unilateral neglect
  • Presence of significant visual deficits
  • Communication disorders that interfere with assessment or intervention
  • Peripheral nerve injury affecting the upper limb
  • Botulinum toxin injection to the affected upper limb within the previous six months
  • History of major orthopedic surgery of the affected upper limb
  • Serious systemic comorbidities
  • History of epileptic seizures

研究组 & 干预措施

Soft Robotic Glove

Experimental

Participants receive conventional Neurodevelopmental Therapy (NDT) combined with a wearable soft robotic glove (SRG) performing standard grip, tripod grip, palmar grip, and 1st-5th finger opposition tasks, 3 sessions/week for 6 weeks

干预措施: Soft Robotic Glove (SRG) (Device)

Leap Motion Controller

Experimental

Participants receive conventional NDT combined with Leap Motion Controller integrated with the Becure HandROM and ErgoActive modules, performing LeapBall (wrist flexion/extension, abduction/adduction), Piano (finger flexion/extension), PinchPeg (precision pinch), and Hold-and-Put (palmar grasp-release) exercises, 3 sessions/week for 6 weeks.

干预措施: Leap Motion Controller (LMC) (Device)

Control Group

Active Comparator

Participants receive NDT alone, supplemented with standard task-oriented hand exercises such as resisted wrist/hand movements, bottle grasp-release, peg transfer, and ball grasp-release activities, 3 sessions/week for 6 weeks.

干预措施: Neurodevelopmental Therapy (NDT) (Behavioral)

结局指标

主要结局

Hand Function - Chedoke Arm and Hand Activity Inventory (CAHAI)

时间窗: Baseline (pre-treatment, week 0) and after 6 weeks of intervention (post-treatment, week 6)

The Chedoke Arm and Hand Activity Inventory (CAHAI) evaluates functional bilateral task performance in individuals with post-stroke hemiplegia. It consists of 9 functional tasks scored on a 7-point scale (1 = total assistance, 7 = complete independence). Higher scores indicate better upper-limb functional performance and independence in daily activities.

Box-and-Block Test (BBT)

时间窗: Baseline (pre-treatment, week 0) and after 6 weeks of intervention (post-treatment, week 6)

The Box and Block Test (BBT) measures unilateral gross manual dexterity. Participants move as many wooden blocks as possible from one compartment of a box to another in 60 seconds. The total number of transferred blocks is recorded; higher scores indicate better hand dexterity and motor coordination.

次要结局

  • Range-of-Motion (ROM)(Baseline (pre-treatment, week 0) and after 6 weeks of intervention (post-treatment, week 6))
  • Surface Electromyography (sEMG)(Baseline (pre-treatment, week 0) and after 6 weeks of intervention (post-treatment, week 6))

研究者

发起方
Medipol University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Taha Ayberk Erdoğan

Physiotherapist (MSc) - Principal Investigator

Medipol University

研究点 (1)

Loading locations...

相似试验